RAD51AP1 and neoplasm: Decreased RAD51AP, encoding an enhancer of RAD51, observed in tumours from ECR patients is consistent with this suggestion, as genetic ablation of RAD51AP1 leads to enhanced sensitivity to chromosome aberrations upon DNA damage [43].